Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
The Diabetes Control and Complications Trial Research Group.
Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial.
JAMA, 276 (1996), pp. 1409-1415
[2.]
The Diabetes Control and Complications Trial Research Group.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med, 329 (1993), pp. 977-986
[3.]
J. Pickup, M. Mattock, S. Kerry.
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.
BMJ, 324 (2002), pp. 705
[4.]
J. Weissberg-Benchell, J. Antisdel-Lomaglio, R. Seshadri.
Insulin pump therapy: a meta-analysis.
Diabetes Care, 26 (2003), pp. 1079-1087
[5.]
R.P. Hoogma, P.J. Hammond, R. Gomis, D. Kerr, D. Bruttomesso, K.P. Bouter, et al.
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
Diabet Med, 23 (2006), pp. 141-147
[6.]
J.L. Colquitt, C. Green, M.K. Sidhu, D. Hartwell, N. Waugh.
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Health Technol Assess, 8 (2004), pp. iii1-iii171
[7.]
P. Scuffham, L. Carr.
The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes.
Diabet Med, 20 (2003), pp. 586-593
[8.]
S. Roze, W.J. Valentine, K.E. Zakrzewska, A.J. Palmer.
Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
Diabet Med, 22 (2005), pp. 1239-1245
[9.]
O. De Solá-Morales, C. Castell, I. Conget, R. Corcoy.
El análisis de coste-efectividad del tratamiento a largo plazo con bombas de infusión continua de insulina no apoya su uso generalizado en la diabetes tipo 1.
Av Diabetología, (2004),
[10.]
I. Conget-Donlo, J.M. Rodríguez-Barrios, I. Levy-Mizrahi, C. Castell-Abat, S. Roze, D. Serrano-Contreras.
Análisis coste-utilidad de las bombas de insulina frente a múltiples dosis diarias de insulina en pacientes con diabetes tipo 1 en España.
Rev Esp Salud Pública, 80 (2006), pp. 679-695
Copyright © 2007. Sociedad Española de Endocrinología y Nutrición
